GGrantIndex
Sort

130,381 grants matching hiv

Strengthening Local University Capacity to Provide Quality Medical Education and HIV Prevention, Care and Treatment under PEPFAR

$945,000
Tesfay Gebrehiwot · Mekelle University · U2G · FY2016 · GH

A Gene Drive Therapy for HIV: single-administration intervention for high-risk groups

$945,000
Leor S Weinberger · J. David Gladstone Institutes · DP1 · FY2021 · DA

Self-Assembling Spike-EBR Nanoparticles as a Vaccine Platform Technology Against SARS-CoV-2 and Future Pandemic Coronaviruses

$945,000
Magnus Adrian Gero Hoffmann · J. David Gladstone Institutes · DP5 · FY2025 · OD

A Gene Drive Therapy for HIV: single-administration intervention for high-risk groups

$945,000
Leor S Weinberger · J. David Gladstone Institutes · DP1 · FY2022 · DA

A Gene Drive Therapy for HIV: single-administration intervention for high-risk groups

$945,000
Leor S Weinberger · J. David Gladstone Institutes · DP1 · FY2023 · DA

BUILDING CAPACITY FOR HIV OPERATIONAL RESEARCH AND PUBLIC HEALTH EVALUATION FOR

$945,000
Jonathan Mshana · National Institute For Medical Research · U2G · FY2011 · PS

Novel Proteomics Approach to HIV-Associated Neurocognitive Disorder & Drug Abuse

$945,000
Stuart A Lipton · Scintillon Institute For Photobiology · DP1 · FY2016 · DA

A Gene Drive Therapy for HIV: single-administration intervention for high-risk groups

$945,000
Leor S Weinberger · J. David Gladstone Institutes · DP1 · FY2020 · DA

Modulation of the immune response to B cell lineage-based immunization by other immune interventions administered in infancy

$944,979
Genevieve Giny Fouda Amou Ou · Weill Medical Coll Of Cornell Univ · P01 · FY2025 · AI

MICROBICIDES IN MODEL SYSTEMS

$944,931
Pennsylvania State Univ Hershey Med Ctr · P01 · FY2002 · AI

Clinical Trial Unit for HIV Prevention and Microbicide Research

$944,912
Kenneth H Mayer · Fenway Community Health Center · UM1 · FY2013 · AI

A NOVEL, LOGICAL APPROACH TO HIV VACCINE DEVELOPMENT

$944,842
University Of Wisconsin Madison · R01 · FY2002 · AI

Correlates and Consequences of Increased Immune Activation in HIV + and - IDUs

$944,831
Martin H Markowitz · Aaron Diamond Aids Research Center · R01 · FY2014 · DA

Preparing for Implementation of Sustained Release Antivirals for HIV Prevention

$944,824
Sarit A Golub · Hunter College · R01 · FY2017 · MH

Virus host interactions in clinical samples

$944,767
Joseph Ziegelbauer · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Baylor College of Medicine Clinical Trial Unit

$944,697
William Thomas Shearer · Baylor College Of Medicine · UM1 · FY2013 · AI

African Association for Health Professions Education and Research

$944,587
Nelson K Sewankambo · Infectious Diseases Institute · R25 · FY2018 · TW

Development of A Lab-on-a-Chip System for Saliva-Based Diagnostics

$944,581
John T McDevitt · Rice University · U01 · FY2011 · DE

GH13-1353, Cote d'Ivoire, TECHNICAL ASSISTANCE IN SUPPORT OF HIV PREVENTION, CARE AND TREATMENT IN THE REPUBLIC OF COTE D’IVOIRE UNDER THE PRESIDENT’S PLAN FOR AIDS RELIEF (PEPFAR)

$944,576
Heather Harrison · Johns Hopkins University · U2G · FY2016 · GH

Diverting homeless youth/chronic homelessness/risk/HIV

$944,574
University Of California Los Angeles · R01 · FY2005 · MH

Integration of infant male circumcision with community health services in Kenya

$944,541
Robert Converse Bailey · University Of Illinois At Chicago · U01 · FY2013 · AI

COMPREHENSIVE HIV PREVENTION, TREATMENT AND CARE PROGRAM FOR THE MINISTRY OF NATI

$944,400
Mamo Girmay Wendatir · Federal Democratic Of Republic/Ethiopia · U2G · FY2008 · PS

Monitoring HAART in HIV-infected parents in Thailand

$944,363
Marc J Lallemant · Harvard School Of Public Health · R01 · FY2008 · HD

Statistical and Data Management Center (SDMC), AIDS Clinical Trials Group (ACTG)

$944,359
Michael David Hughes · Harvard School Of Public Health · UM1 · FY2022 · AI

Fox COBRE Phase II Admin Core

$944,312
Joseph M Fox · University Of Delaware · P20 · FY2023 · GM